Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amorphous Calcium Carbonate in Late-Stage Solid Cancer
NCT03582280Phase 1Terminated
- Sponsor
- Amorphical
- Start
- Jul 2018
- Primary completion
- Jun 2022
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of amorphous calcium carbonate in solid tumor, sponsored by Amorphical. Primary endpoints: Visual Analogue Scale at Week 24, ECOG Performance Status at Week 24 and 2 more. Started Jul 2018; status: terminated.
02
Drugs
amorphous calcium carbonate
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03582280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582280.